# Delivery Order #SPE2DR26FQXL3

DMS Pharmaceutical Group to Supply ILARIS Under Delivery Order

**Buyer:** Defense Logistics Agency

**Award Amount:** $14,643.01
**Ceiling:** $14,643.01

**Awarded:** July 02, 2026
**Period of Performance:** Jul 02, 2026 - Jul 24, 2026

**Identifier:** SPE2DR26FQXL3
**NAICS:** 424210

This delivery order, issued under DMS Pharmaceutical Group Inc.’s indefinite-delivery contract, procures ILARIS (canakinumab) supplied as 150 mg/mL vials. The order supports the government’s pharmaceutical supply needs by providing a specific medication through an established procurement vehicle. DMS Pharmaceutical Group, a pharmaceutical distributor, is the named recipient; no parent company is identified in the available data. The scope shown is limited to supplying the specified product, with delivery associated with Park Ridge, Illinois. The underlying IDV runs from late 2025 into 2026, while this order has a short performance period in mid-2026. The data does not identify whether the order was competed or sole-source, nor does it provide a solicitation, acquisition program, subcontractors, or details of earlier related performance.

### Description

4572329195!ILARIS 150 MG/ML VIALML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FQXL3_9700_SPE2DR25D9353_9700)
